Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Multimodal Imaging in Rectal Cancer & Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery
- Status
- RECRUITING
- Phase
- PHASE3
Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Pancreatic Cancer Detection Consortium
- Status
- RECRUITING
- Phase
- N/A
Namodenoson Treatment of Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2
- Status
- COMPLETED
- Phase
- NA
Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients
- Status
- COMPLETED
- Phase
- N/A
The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- N/A
Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients
- Status
- RECRUITING
- Phase
- N/A
Ex-vivo Ultrasound Guided Radiofrequency Ablation on Pancreatic Solid Lesions
- Status
- TERMINATED
- Phase
- NA
Newly Emerging Immunotherapy for Pancreatic Cancer Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
- Status
- RECRUITING
- Phase
- N/A
Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer
- Status
- RECRUITING
- Phase
- NA
Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients
- Status
- RECRUITING
- Phase
- PHASE2
XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer
- Status
- RECRUITING
- Phase
- NA